Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Therapeutic Advances in Infectious Disease
|
July 17, 2019
A current appraisal of evidence for the approach to sepsis and septic shock
Jack Varon, Rebecca M Baron
F1000Research
|
May 10, 2016
Recent advances in understanding and treating ARDS
Rebecca M Baron, Bruce D Levy
The Journal of Clinical Investigation
|
March 16, 2026
The bug, the burden, and the biology: beyond host-centric phenotyping in sepsis
Georgios D Kitsios, Rebecca M Baron
JCI Insight
|
January 25, 2019
Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome
Joshua A Englert, Christopher Bobba, Rebecca M Baron
Biochemistry and Biophysics Reports
|
April 12, 2016
The Relationship between RUVBL1 (Pontin, TIP49, NMP238) and BCL6 in Benign and Malignant Human Lymphoid Tissues
Beverly W Baron, Rebecca M Baron, Joseph M Baron
Critical Care Medicine
|
March 14, 2002
High-mobility group-I/Y proteins: Potential role in the pathophysiology of critical illnesses
Irvith M. Carvajal, Rebecca M. Baron, Mark A. Perrella
Biochimica Et Biophysica Acta
|
January 6, 2015
The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases
Beverly W Baron, Rebecca M Baron, Joseph M Baron
Critical Care Medicine
|
January 10, 2002
High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses
Irvith M Carvajal, Rebecca M Baron, Mark A Perrella
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 27, 2011
Genetically manipulated mouse models of lung disease: potential and pitfalls
Rebecca M Baron, Alexander J S Choi, Caroline A Owen, et al.
FEBS Letters
|
February 19, 2008
High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression
Rina Takamiya, Rebecca M Baron, Shaw-Fang Yet, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Therapeutic Advances in Infectious Disease
|
July 17, 2019
A current appraisal of evidence for the approach to sepsis and septic shock
Jack Varon, Rebecca M Baron
F1000Research
|
May 10, 2016
Recent advances in understanding and treating ARDS
Rebecca M Baron, Bruce D Levy
The Journal of Clinical Investigation
|
March 16, 2026
The bug, the burden, and the biology: beyond host-centric phenotyping in sepsis
Georgios D Kitsios, Rebecca M Baron
JCI Insight
|
January 25, 2019
Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome
Joshua A Englert, Christopher Bobba, Rebecca M Baron
Biochemistry and Biophysics Reports
|
April 12, 2016
The Relationship between RUVBL1 (Pontin, TIP49, NMP238) and BCL6 in Benign and Malignant Human Lymphoid Tissues
Beverly W Baron, Rebecca M Baron, Joseph M Baron
Critical Care Medicine
|
March 14, 2002
High-mobility group-I/Y proteins: Potential role in the pathophysiology of critical illnesses
Irvith M. Carvajal, Rebecca M. Baron, Mark A. Perrella
Biochimica Et Biophysica Acta
|
January 6, 2015
The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases
Beverly W Baron, Rebecca M Baron, Joseph M Baron
Critical Care Medicine
|
January 10, 2002
High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses
Irvith M Carvajal, Rebecca M Baron, Mark A Perrella
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 27, 2011
Genetically manipulated mouse models of lung disease: potential and pitfalls
Rebecca M Baron, Alexander J S Choi, Caroline A Owen, et al.
FEBS Letters
|
February 19, 2008
High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression
Rina Takamiya, Rebecca M Baron, Shaw-Fang Yet, et al.
Page
of 13